Bridgewater Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$508K Sell
9,586
-465
-5% -$37.2K 0.03% 244
2025
Q4
$921K Buy
10,051
+123
+1% +$12.1K 0.06% 146
2025
Q3
$981K Buy
9,928
+160
+2% +$16.6K 0.07% 130
2025
Q2
$1.04M Buy
9,768
+158
+2% +$16K 0.08% 127
2025
Q1
$987K Buy
+9,610
New +$968K 0.09% 119
2022
Q3
Sell
-6,139
Closed -$229K 144
2022
Q2
$229K Sell
6,139
-225
-4% -$9.16K 0.05% 205
2022
Q1
$282K Buy
6,364
+289
+5% +$12.5K 0.07% 195
2021
Q4
$258K Buy
6,075
+172
+3% +$7.23K 0.06% 213
2021
Q3
$256K Sell
5,903
-115
-2% -$5.09K 0.07% 205
2021
Q2
$257K Sell
6,018
-150
-2% -$6.31K 0.08% 202
2021
Q1
$255K Buy
+6,168
New +$233K 0.13% 141

Other funds holding BSX

Bridgewater Advisors's BSX Position: Q1 2026 in Review

Bridgewater Advisors reduced its Boston Scientific (BSX) stake by 4.6% in Q1 2026, selling an estimated $37.2K and leaving 9,586 shares worth $508K. The position accounts for 0.03% of the portfolio, ranked #244.

Bridgewater Advisors first reported a position in BSX in Q1 2021 and has held it in 11 quarters since. The position peaked at $1.04M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Bridgewater Advisors held 9,586 shares of Boston Scientific worth $508K as of Q1 2026.
  • Bridgewater Advisors sold 465 Boston Scientific shares in Q1 2026, an estimated $37.2K.
  • Boston Scientific made up 0.03% of Bridgewater Advisors's portfolio in Q1 2026, its #244 holding.
  • Bridgewater Advisors first reported a position in Boston Scientific in Q1 2021 and has held it in 11 quarters since.
  • Bridgewater Advisors's Boston Scientific position peaked at $1.04M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.